NCT07765147Completed
Evaluating iCare COMPASS as a Visual Field Diagnostic Tool
Source: ClinicalTrials.gov · Last updated 14 Aug 2026
Brief summary (registry, in English)
this study seeks to compare the Humphrey Visual Field Analyzer and iCare COMPASS for both clinical accuracy and operational advantages.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 11 Aug 2026
- Start date
- 7 Feb 2025
- Primary completion date
- 16 Jan 2026
- Lead sponsor
- Indiana University
- Diseases
- Glaucoma
- NCT number
- NCT07765147
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 7 Feb 2025 to the primary completion date, 16 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Those who are unwilling or unable to provide consent
- Those for which English is not their first language
Who the study is looking for
- All consenting patients who arrive for glaucoma management appointments for objective(s) 2.1.1, 2.2.2
- Patient groups arriving for glaucoma management that will be targeted for enrollment include: glaucoma suspect patients, those with cataracts, optic atrophy, macular degeneration, macular pathology, and vascular diseases of the retina
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eugene and Marilyn Glick Eye Institute Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.